Anti-Ge2: further evidence for lack of clinical significance
By: D. Karunasiri, F. Lowder, N. Ostrzega and D. Goldfinger
Paid access
|Dec 2019Authors
D. Karunasiri
Los Angeles County– Olive View/UCLA Medical Center, Department of Pathology, California, United States
F. Lowder
Los Angeles County–Olive View/UCLA Medical Center, Department of Pathology, California, United States
N. Ostrzega
David Geffen School of Medicine at UCLA, Department of Pathology, Los Angeles County–Olive View/UCLA Medical Center, Sylmar, CA, United States
D. Goldfinger
Division of Transfusion Medicine, Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Department of Pathology and Laboratory Medicine, Los Angeles County–Olive View/UCLA Medical Center, Los Angeles, CA, United States
DOI: https://doi.org/10.21307/immunohematology-2019-112 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 156 - 157
Published on: Dec 1, 2019
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2019 D. Karunasiri, F. Lowder, N. Ostrzega, D. Goldfinger, published by American National Red Cross
This work is licensed under the Creative Commons License.